ニーズの概略

PfizerがInflammation & Immunologyに関する技術を募集しています。

募集内容

The Inflammation & Immunology Research Unit, led by Michael Vincent, Chief Scientific Officer, is focused on discovering, evolving and developing the next generation of therapies for immune-mediated diseases. Pfizer is interested in entering into strategic relationships with innovative collaborators to develop increasingly novel and differentiated therapies in Rheumatology, Gastroenterology and Medical Dermatology.

We are interested in establishing alliances to develop and access:

-Rheumatoid Arthritis -Systemic Lupus Erythematosus -Inflammatory Bowel Disease

-Nonalcoholic steatohepatitis (NASH)

-Atopic Dermatitis

-Other indications with high unmet need that are mechanistically related to those above Specific areas of interest include:

-Cytokines and their signaling pathways

-Adaptive Immunity, Lymphocyte biology including Th17 lymphocytes

-Regulatory cells and Tolerance induction

-Host-microbial interactions and microbiome with an interest in epithelial barrier -Innate Immunity and Innate Lymphoid Cell biology

-Oxidative stress modulators

-Anti-fibrotics

-Technology platforms and products to help understand patient segmentation in the disease areas of interest and develop precision medicine strategies for innovative portfolio products

-Technology platforms and products that allow for greater tissue and cell specific delivery

以上の技術ニーズは、Pfizerが公式ウェブサイトにて開示したものを取得したものであり、弊社は当該ニーズ提供者の代理人ではありません。